Deutsche Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26B Sell
3,547,772
-259,865
-7% -$263M 1.08% 11
2025
Q4
$4.09B Buy
3,807,637
+529,477
+16% +$506M 1.33% 9
2025
Q3
$2.5B Sell
3,278,160
-224,313
-6% -$167M 0.84% 14
2025
Q2
$2.73B Sell
3,502,473
-1,055
-0% -$820K 1.01% 12
2025
Q1
$2.89B Buy
3,503,528
+477,889
+16% +$398M 1.15% 9
2024
Q4
$2.34B Sell
3,025,639
-230,366
-7% -$191M 0.91% 13
2024
Q3
$2.88B Buy
3,256,005
+181,783
+6% +$163M 1.17% 8
2024
Q2
$2.78B Sell
3,074,222
-64,280
-2% -$51.4M 1.26% 8
2024
Q1
$2.44B Buy
3,138,502
+318,722
+11% +$227M 1.13% 11
2023
Q4
$1.64B Buy
2,819,780
+118,971
+4% +$69.4M 0.84% 14
2023
Q3
$1.45B Sell
2,700,809
-224,540
-8% -$116M 0.94% 13
2023
Q2
$1.37B Buy
2,925,349
+87,500
+3% +$36.7M 0.73% 20
2023
Q1
$975M Buy
2,837,849
+121,643
+4% +$41M 0.54% 29
2022
Q4
$994M Sell
2,716,206
-148,442
-5% -$52.6M 0.57% 29
2022
Q3
$926M Buy
2,864,648
+284,394
+11% +$90.1M 0.56% 33
2022
Q2
$837M Buy
2,580,254
+52,850
+2% +$15.9M 0.47% 49
2022
Q1
$724M Sell
2,527,404
-987,138
-28% -$254M 0.34% 61
2021
Q4
$971M Buy
3,514,542
+449,994
+15% +$114M 0.44% 43
2021
Q3
$708M Buy
3,064,548
+483,698
+19% +$119M 0.34% 55
2021
Q2
$592M Buy
2,580,850
+216,785
+9% +$43.5M 0.29% 71
2021
Q1
$442M Buy
2,364,065
+325,628
+16% +$63.7M 0.24% 85
2020
Q4
$344M Sell
2,038,437
-102,020
-5% -$15.2M 0.21% 105
2020
Q3
$317M Sell
2,140,457
-101,754
-5% -$15.7M 0.22% 99
2020
Q2
$368M Buy
2,242,211
+337,050
+18% +$51.7M 0.28% 68
2020
Q1
$264M Sell
1,905,161
-968,183
-34% -$133M 0.24% 88
2019
Q4
$378M Buy
2,873,344
+183,454
+7% +$21.3M 0.25% 82
2019
Q3
$301M Sell
2,689,890
-492,584
-15% -$54.8M 0.21% 97
2019
Q2
$353M Buy
3,182,474
+1,009,612
+46% +$119M 0.21% 88
2019
Q1
$282M Sell
2,172,862
-191,645
-8% -$23.3M 0.17% 123
2018
Q4
$274M Sell
2,364,507
-848,660
-26% -$94.8M 0.19% 112
2018
Q3
$345M Sell
3,213,167
-1,311,412
-29% -$131M 0.17% 115
2018
Q2
$386M Sell
4,524,579
-440,462
-9% -$36.2M 0.19% 103
2018
Q1
$384M Buy
4,965,041
+2,015,221
+68% +$162M 0.18% 115
2017
Q4
$249M Buy
2,949,820
+447,714
+18% +$38.1M 0.16% 131
2017
Q3
$214M Sell
2,502,106
-525,967
-17% -$43.1M 0.15% 148
2017
Q2
$249M Buy
3,028,073
+1,308,593
+76% +$107M 0.18% 118
2017
Q1
$145M Sell
1,719,480
-206,460
-11% -$16.5M 0.11% 216
2016
Q4
$142M Sell
1,925,940
-536,335
-22% -$39.9M 0.11% 199
2016
Q3
$198M Sell
2,462,275
-888,379
-27% -$71.1M 0.14% 151
2016
Q2
$264M Buy
3,350,654
+892,012
+36% +$67.2M 0.19% 112
2016
Q1
$177M Sell
2,458,642
-421,182
-15% -$31.9M 0.13% 170
2015
Q4
$243M Buy
2,879,824
+936,891
+48% +$77.7M 0.17% 134
2015
Q3
$163M Sell
1,942,933
-1,341,784
-41% -$113M 0.13% 188
2015
Q2
$274M Buy
3,284,717
+207,855
+7% +$15.8M 0.18% 135
2015
Q1
$224M Sell
3,076,862
-2,694,914
-47% -$192M 0.14% 169
2014
Q4
$398M Buy
5,771,776
+223,332
+4% +$15.1M 0.25% 82
2014
Q3
$360M Buy
5,548,444
+1,500,633
+37% +$95M 0.22% 85
2014
Q2
$252M Sell
4,047,811
-1,907,926
-32% -$114M 0.17% 129
2014
Q1
$351M Buy
5,955,737
+23,574
+0.4% +$1.32M 0.25% 82
2013
Q4
$303M Sell
5,932,163
-304,967
-5% -$15.3M 0.22% 100
2013
Q3
$314M Sell
6,237,130
-756,660
-11% -$39.6M 0.23% 83
2013
Q2
$344M Buy
+6,993,790
New +$381M 0.28% 64

Other funds holding LLY

Deutsche Bank's LLY Position: Q1 2026 in Review

Deutsche Bank reduced its Eli Lilly (LLY) stake by 6.8% in Q1 2026, selling an estimated $263M and leaving 3,547,772 shares worth $3.26B. The position accounts for 1.08% of the portfolio, ranked #11.

Deutsche Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.09B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Deutsche Bank held 3,547,772 shares of Eli Lilly worth $3.26B as of Q1 2026.
  • Deutsche Bank sold 259,865 Eli Lilly shares in Q1 2026, an estimated $263M.
  • Eli Lilly made up 1.08% of Deutsche Bank's portfolio in Q1 2026, its #11 holding.
  • Deutsche Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Eli Lilly position peaked at $4.09B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.